戻る Agendas
Concurrent Breakout Session 1A: Adaptive Design Case Studies
Session Chair(s)
Yili Pritchett, PHD
Senior Director, Global Development
Astellas Pharma Inc., United States
Speaker(s)
Sequential Stage Design in the Gazyva Registration Trial
Chia-Wen Ko, PHD
FDA, United States
Mathematical Statistician
2-Stage Design in the Crofelemer Pivotal Program
M. Scott Harris, MD, MS, FACP
Lyric Pharmaceuticals, United States
Principal
Moving Drugs from Phase 2 into Phase 3
Brenda L. Gaydos, PHD
United States
Q&A Panel Discussion
Sue-Jane Wang, PHD, MA, MS
FDA, United States
Mathematician Statistician